Human Vaccines Project Inc
- Assets
- $2.9m
- Revenue
- $3.0m
- Investments
- $0.0
- Employees
- 9
- Location
- New York, NY
- Founding
- 02/2015
- Data as of
- 12/2023
- EIN
- 47-2364966
Organization Overview
Human Vaccines Project Inc, operating under the name (formerly Human Vaccines Project), is located in New York, NY. The organization was established in 2015. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. As of 12/2023, (formerly Human Vaccines Project) employed 9 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. (formerly Human Vaccines Project) is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, (formerly Human Vaccines Project) generated $3.0m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.7% each year. All expenses for the organization totaled $3.2m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, (formerly Human Vaccines Project) has awarded 45 individual grants totaling $10,678,242. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO DECODE THE HUMAN IMMUNE SYSTEM TO ACCELERATE VACCINE AND THERAPEUTIC DEVELOPMENT
Describe the Organization's Program Activity:
Part 3 - Line 4a
MICHELSON PRIZES - SUPPORTS YOUNG RESEARCHERS WITH TRANSFORMATIVE IDEAS IN HUMAN IMMUNOLOGY.
BASIC STUDY AND ANALYSIS TO THE INTRODUCTION OF IMMUNOME MONITORING KITS AND SITE ESTABLISHEMENT
RULES OF IMMUNITY - COVID VACCINES INITIATIVE CONDUCTS CUTTING EDGE RESEARCH INTO THE THE IMMUNOLOGY BEHIND COVID-19 VACCINES, AND PROVIDES A FORUM FOR SCIENTISTS AND POLICY MAKERS ON LATEST COVID-19 RESEARCH VIA THE GLOBAL LAB MEETING AND COVID REPORT.
BIOINFORMATICS AND HUMAN IMMUNOME - EXTENSIVE IMMUNOLOGICAL DATA-SETS GENERATED BY HVP CLINICAL STUDIES. BIOINFORMATICS PROGRAM APPLIES ADVANCED STATISTICAL, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE APPROACHES TO ANALYZE IMMUNOLOGICAL DATA-SETS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jane Metcalfe Board Chair | OfficerTrustee | 1 | $0 |
Rey Ramsey Board Member | Trustee | 1 | $0 |
Kenneth Holroyd MD Board Member/fin, Audit & Risk Mgmt | Trustee | 1 | $0 |
Douglas Richman MD Board Member | Trustee | 1 | $0 |
Jose Maria Fernandez Board Member/fin, Audit & Risk Mgmt | Trustee | 1 | $0 |
Linda Avey Board Member | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Immorbidity Bv Scientific Consulting | 12/30/20 | $257,571 |
Olando Gmbh Marketing And Web Development | 12/30/20 | $196,518 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,030,249 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,030,249 |
| Total Program Service Revenue | $0 |
| Investment income | $14,846 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $3,031,421 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $581,760 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $297,056 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $665,825 |
| Compensation of current officers, directors, key employees. | $133,165 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $410,549 |
| Pension plan accruals and contributions | $18,082 |
| Other employee benefits | $33,005 |
| Payroll taxes | $67,191 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $38,341 |
| Fees for services: Accounting | $171,869 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $505,153 |
| Advertising and promotion | $0 |
| Office expenses | $68,571 |
| Information technology | $17,545 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $212,091 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $15,305 |
| All other expenses | $0 |
| Total functional expenses | $3,193,387 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $454,789 |
| Savings and temporary cash investments | $1,283,399 |
| Pledges and grants receivable | $1,000,543 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $4,971 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $156,120 |
| Total assets | $2,899,822 |
| Accounts payable and accrued expenses | $136,991 |
| Grants payable | $867,699 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,004,690 |
| Net assets without donor restrictions | $1,895,132 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $2,899,822 |
Grants Awarded
Over the last fiscal year, Human Vaccines Project Inc has awarded $581,760 in support to 5 organizations.
| Grant Recipient | Amount |
|---|---|
WASHINGTON UNIVERSITY IN ST LOUIS PURPOSE: RESEARCH FUNDING | $150,000 |
JOAN & SANFORD WEIL MEDICAL COLLEGE OF CORNELL UNIVERSITY PURPOSE: RESEARCH FUNDING | $150,000 |
THE ROCKEFELLER UNIVERSITY PURPOSE: RESEARCH FUNDING | $150,000 |
UNIVERSITY OF NEW MEXICO PURPOSE: RESEARCH FUNDING | $58,860 |
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE PURPOSE: RESEARCH FUNDING | $72,900 |